J Hoyer1. 1. Klinik für Innere Medizin, Nephrologie und Internistische Intensivmedizin, Klinikum der Philipps-Universität, Baldingerstr. 1, 35033, Marburg, Deutschland, hoyer@med.uni-marburg.de.
Abstract
UNLABELLED: The association between high salt (NaCl) intake and increased blood pressure has been demonstrated in a multitude of studies. Clear evidence for a blood pressure lowering effect of a reduction in dietary NaCl has also been reported. In contrast to the antihypertensive effect of NaCl reduction, from a clinical scientific perspective a positive effect on cardiovascular mortality has not been sufficiently demonstrated. Often the proven blood pressure lowering effect of reduced NaCl intake was extrapolated to an effect on the cardiovascular risk. This article describes the current data situation and discusses the effects of NaCl restriction in people with hypertension and patients with cardiovascular diseases in detail. IN SUMMARY: moderate restriction of NaCl to 6 g/day is recommended for patients with hypertension or cardiovascular comorbidities, intensive reduction to ≤3 g/day is not recommended and for patients with few comorbidities an NaCl intake of up to 10 g/day has no obvious disadvantages.
UNLABELLED: The association between high salt (NaCl) intake and increased blood pressure has been demonstrated in a multitude of studies. Clear evidence for a blood pressure lowering effect of a reduction in dietary NaCl has also been reported. In contrast to the antihypertensive effect of NaCl reduction, from a clinical scientific perspective a positive effect on cardiovascular mortality has not been sufficiently demonstrated. Often the proven blood pressure lowering effect of reduced NaCl intake was extrapolated to an effect on the cardiovascular risk. This article describes the current data situation and discusses the effects of NaCl restriction in people with hypertension and patients with cardiovascular diseases in detail. IN SUMMARY: moderate restriction of NaCl to 6 g/day is recommended for patients with hypertension or cardiovascular comorbidities, intensive reduction to ≤3 g/day is not recommended and for patients with few comorbidities an NaCl intake of up to 10 g/day has no obvious disadvantages.
Authors: Hiddo J Lambers Heerspink; Martin H de Borst; Stephan J L Bakker; Gerjan J Navis Journal: Nat Rev Nephrol Date: 2012-12-18 Impact factor: 28.314
Authors: Andrew Mente; Martin J O'Donnell; Gilles Dagenais; Andy Wielgosz; Scott A Lear; Matt J McQueen; Ying Jiang; Wang Xingyu; Bo Jian; K Burco T Calik; Ayse A Akalin; Prem Mony; Anitha Devanath; Afzal H Yusufali; Patricio Lopez-Jaramillo; Alvaro Avezum; Khaled Yusoff; Annika Rosengren; Lanthe Kruger; Andrés Orlandini; Sumathi Rangarajan; Koon Teo; Salim Yusuf Journal: J Hypertens Date: 2014-05 Impact factor: 4.844
Authors: Andrew Smyth; Martin J O'Donnell; Salim Yusuf; Catherine M Clase; Koon K Teo; Michelle Canavan; Donal N Reddan; Johannes F E Mann Journal: Am J Hypertens Date: 2014-02-07 Impact factor: 2.689
Authors: Maartje C J Slagman; Femke Waanders; Marc H Hemmelder; Arend-Jan Woittiez; Wilbert M T Janssen; Hiddo J Lambers Heerspink; Gerjan Navis; Gozewijn D Laverman Journal: BMJ Date: 2011-07-26